Skip to main content

Table 2 Sample description for cytokine quantification

From: The association between sex-related interleukin-6 gene polymorphisms and the risk for cerebral palsy

Characteristic

CP cases

Control

Total (%)

M/F (n)

Total (%)

M/F (n)

Type of CP

    

CP with spastic

58 (68.2)

35/23

–

–

CP without spastic

27 (31.8)

19/8

–

–

Total

85 (100)

54/31

75 (100)

62/13

Gestational age

    

Term (≥37 weeks)

56 (65.9)

41/15

70 (93.3)

57/13

Preterm (<37 weeks)

29 (34.1)

13/16

5 (6.7)

5/0

Total

85 (100)

54/31

75 (100)

62/13

Birth weight

    

≥2,500 g

61 (71.8)

43/18

71 (94.7)

59/12

<2,500 g

24 (28.2)

11/13

4 (5.3)

3/1

Total

85 (100)

54/31

75 (100)

62/13

Birth asphyxia

    

No asphyxia

51 (60.0)

32/19

73 (97.3)

61/12

Asphyxia

34 (40.0)

22/12

2 (2.7)

1/1

Total

85 (100)

54/31

75 (100)

62/13

Complication

    

With PVL

17 (20.0)

11/6

–

–

Without PVL

68 (80.0)

43/25

–

–

With MR

62 (72.9)

37/25

–

–

Without MR

23 (27.1)

17/6

–

–

With HIE

31 (36.5)

20/11

–

–

Without HIE

54 (63.5)

34/20

–

–

Maternal factors

    

PROM

19 (22.4)

8/11

7 (9.3)

5/2

No PROM

66 (77.6)

46/20

68 (90.7)

57/11

TPL

20 (23.5)

15/5

15 (20.0)

11/4

No TPL

65 (76.5)

39/26

60 (80.0)

51/9

PIH

8 (9.4)

5/3

6 (8.0)

5/1

No PIH

77 (90.6)

49/28

69 (92.0)

57/12

  1. CP, cerebral palsy; M, male; F, female; PVL, periventricular leukomalacia; MR, mental retardation; HIE, hypoxic ischemic encephalopathy; PROM, premature rupture of membrane; TPL, threatened premature labor; PIH, pregnancy-induced hypertension.